万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://chemistry-europe.onlinelibrary.wiley.com/journal/18607187
3、投稿网址：https://www.editorialmanager.com/cmdc
4、官网邮箱：chemmedchem@Chemistry-Europe.org
5、官网电话：+49 6201 606 351
6、期刊刊期：双月刊，一年出版24期。
2022年1月14日星期五
投稿须知【官网信息】
ChemMedChem
Notice to Authors
In Brief
Quick Checklist: Submission
Essential
i.Write in British or American English.ii.Include all text, Schemes, Figures, Tables, and the Table of Contents text and image at the appropriate position in a single manuscript file. Refer to the guidance for preparing graphics.iii.Include Supporting Information (where applicable) as a separate PDF file and media and data files as appropriate. See Section 3 for details.iv.Include a short cover letter in which the relevance and importance of the work are succinctly outlined.v.Include your suggestions for impartial reviewers and Editorial Advisory Board member(s) to assess your manuscript, and note those with whom you have a conflict of interest.vi.Submit all files through Editorial Manager.vii.Inform us if you have a related paper in submission/peer review/publishing elsewhere.viii.Inform us of any corresponding preprint(s) posted.
Helpful for faster evaluation
i.Use the Microsoft Word and ChemDraw templates. Embed Figures, Schemes, Tables, and their respective captions as they are mentioned in the text, and not at the end.ii.Inform us if the manuscript has been professionally edited by a service such as Wiley Editing Services.iii.Inform us if the manuscript has previously been submitted to another Wiley journal and/or if you have a related paper in submission/peer review/publishing elsewhere.
Quick Checklist: Manuscript Contents
i.Abstract (max. 150 words).ii.Comprehensive experimental section and characterization data (see Section 3.4).iii.Supporting Information (see Sections 3.2 and 3.4).iv.Table of Contents graphic with an accompanying text up to 50 words (max. 450 characters with spaces) and an appropriate image (5.5×5.0 cm (max. width × height) or 11.5×2.5 cm (max. width × height), min. font size: 6–7 points); see Sections 3.3 and Section 5.6).v.Keywords in alphabetical order including at least two from the core keyword list (see Section 3.6).vi.Declaration of approval for animal, human, or tissue experiments in the Editorial Manager submission form AND in the Experimental Section of the manuscript/Supporting Information (see Section 5.1.2).vii.For Reviews only: a frontispiece image (18×19.5 cm (width x height); guide), biographies (70–100 words), and portrait photographs of the author(s). For Concepts and Perspectives, biographies are optional.
Quick Checklist: After Acceptance
Essential
i.Upload the manuscript file and Supporting Information (if applicable) as separate files through the "Manuscripts for Production" menu on your personal homepage in Editorial Manager. PDF files are required for the Accepted Article format (published immediately after acceptance and before copy editing), and a Word file (.doc, .docx) is required for preparation of the proof and the Early View article (see Section 4). Please provide short and informative descriptions with each uploaded Supporting Information file; e.g., "Spreadsheet for data in Figure 1". After uploading these files, the next opportunity to make changes will be when you receive the proofs for correction.ii.All graphics must be included in the relevant Word or PDF file in the appropriate position (not separately). Embed all chemical structures in ChemDraw format (.cdx, ChemDraw template) and all other images as high-resolution (300 dpi) .jpeg, .tif, .png, or similar in the manuscript text file. Each Scheme and Figure should be embedded as a single image (see Section 3.3).
Optional
i.Suggest a cover image (21×16 cm (width x height); guide), which adheres to Section 5.6 of these guidelines. Bright, vibrant images are preferred.
1. About the Journal
ChemMedChem is a journal published on behalf of Chemistry Europe, an association of 16 European chemical societies. It is published by Wiley-VCH and is a sister journal of Angewandte Chemie, Chemistry—A European Journal, ChemBioChem, and other Chemistry Europe journals. All general formal aspects of manuscript styling are the same within this family of journals.
Issues of ChemMedChem are published twice a month and contain articles at the interface of chemistry, biology, and medicine. The journal covers drug design, development, and delivery, with a focus on traditional (small-molecule) medicinal chemistry, nanomedicine, theranostics, cheminformatics in drug discovery, biologics, and macromolecular therapies. Visit the journal´s Overview page for more detail.
Book Reviews and Conference Reports are commissioned and evaluated internally. Submitted manuscripts are evaluated by professional editors and, those deemed suitable for the journal in terms of scope, quality, and novelty, are subject to peer review. Contributions that are not considered suitable for the journal are returned to the author(s) without external review; the editor may recommend transferal to an appropriate sister journal simultaneously. When a manuscript is sent for external review, the editor will avoid any known conflict of interest. Reviewers suggested by the author(s) may or may not be invited, at the editor´s discretion; the editor will exclude named opposed reviewers, subject to the ethical guidelines. ChemMedChem operates a strict single-blind peer-review process. After peer review, a decision of accept, reject, or revision is made on the basis of the reviewers′ comments and the judgment of the editor. Revised manuscripts are evaluated by the editor and, if required, by reviewers. In case of ambiguity, a board member or a top adjudicative reviewer is consulted for advice. All invited and transferred manuscripts, as well as contributions by the journal´s board members, undergo the same peer-review process (as outlined above) as unsolicited manuscripts. The final decision to accept or reject a manuscript rests with the editor. The editor may arrange for a rejected manuscript to be transferred to a sister journal where it may be published after appropriate revision. If authors choose to pursue this option, their manuscript along with the reviewer reports is transferred to the receiving journal to expedite any further evaluation and the editor′s decision. The primary objective of this collaboration is to reduce the incidence of redundant reviews, thus lessening the burden on the already overstretched community of reviewers.
……
更多详情：
https://chemistry-europe.onlinelibrary.wiley.com/hub/journal/18607187/notice-to-authors
